Class 3. Pulmonary Hypertension Associated with Lung Disease

Vitamin D Levels and Cardiopulmonary Status in Infants with Acute Bronchiolitis

Ana Estalella-Mendoza, Ana Castellano-Martinez, Jose Carlos Flores-Gonzalez, Lorena Estepapedregosa, Patricia Rodriguez-Campoy, Moises Rodriguez-GonzalezPuerta del Mar University Hospital. Spain Indian PediatricsIndian Pediatr 2022; 59: 384-387DOI: Not Available AbstractBackground: To assess association of Vitamin D deficiency with cardiac and pulmonary status in infants with acute bronchiolitis.Methods: Infants hospitalized with acute bronchiolitis were enrolled and classified as those with serum […]

Vitamin D Levels and Cardiopulmonary Status in Infants with Acute Bronchiolitis Read More »

Cardiac involvement in two rare neuromuscular diseases: LAMA2-related muscular dystrophy and SELENON-related myopathy

Karlijn Bouman, Madelief Gubbels, Frederik M. A. van den Heuvel, Jan T. Groothuis, Corrie E. Erasmus, Robin Nijveldt, Floris E. A. Udink ten Cate, Nicol C. VoermansRadboud University Medical Center and Amalia Children’s Hospital. Netherlands Neuromuscular DisordersNeuromuscul Disord 2022; 32: 635-642DOI: 10.1016/j.nmd.2022.06.004 AbstractLAMA2-related muscular dystrophy (LAMA2-MD) and SELENON(SEPN1)-related myopathy (SELENON-RM) are rare neuromuscular diseases caused by

Cardiac involvement in two rare neuromuscular diseases: LAMA2-related muscular dystrophy and SELENON-related myopathy Read More »

Effects of Ponderal Index on Neonatal Mortality and Morbidities in Extremely Premature Infants

Jae Kyoon Hwang, Ha-Na Kang, Ja-Hye Ahn, Hyun Ju Lee, Hyun-Kyung Park, Chang-Ryul KimHanyang University Guri Hospital. Cheongju St. Mary’s Hospital. Hanyang University Seoul Hospital. Republic of Korea Journal of Korean Medical ScienceJ Korean Med Sci 2022; 37: DOI: 10.3346/jkms.2022.37.e198 AbstractBackground: To evaluate how intrauterine stress affects extremely premature infants in terms of intrauterine growth restriction. We

Effects of Ponderal Index on Neonatal Mortality and Morbidities in Extremely Premature Infants Read More »

Oral hymecromone decreases hyaluronan in human study participants

Joelle I. Rosser, Nadine Nagy, Riya Goel, Gernot Kaber, Sally Demirdjian, Jamie Saxena, Jennifer B. Bollyky, Adam R. Frymoyer, Ana E. Pacheco-Navarro, Elizabeth B. Burgener, Jayakumar Rajadas, Zhe Wang, Olga Arbach, Colleen E. Dunn, Anissa Kalinowski, Carlos E. Milla, Paul L. BollykyStanford University. UCSF School of Pharmacy. Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität Zu Berlin

Oral hymecromone decreases hyaluronan in human study participants Read More »

Response categorization and outcomes in extremely premature infants born at 22-26 weeks gestation that received inhaled nitric oxide for hypoxic respiratory failure

Timothy J. Boly, John M. Dagle, Jonathan M. Klein, Danielle R. Rios, Patrick J. McNamara, Regan E. GiesingerUniversity of Iowa.United States Journal of PerinatologyJ Perinatol 2023; 43: 324-331DOI: 10.1038/s41372-022-01582-4 AbstractObjective: To evaluate the outcomes of extremely premature infants who received inhaled nitric oxide(iNO) for hypoxic respiratory failure(HRF).Study design: Retrospective analysis of 107 infants born 22-26 weeks gestation who

Response categorization and outcomes in extremely premature infants born at 22-26 weeks gestation that received inhaled nitric oxide for hypoxic respiratory failure Read More »

Review of the Pathologic Characteristics in Myhre Syndrome: Gain-of-Function Pathogenic Variants in SMAD4 cause a Multisystem Fibroproliferative Response

Lois J. Starr, Mark E. Lindsay, Deborah Perry, Gregory Gheewalla, Paul A. VanderLaan, Adnan Majid, Charlie Strange, George-Claudiu Costea, Adrian Lungu, Angela E. LinUniversity of Nebraska Medical Center. Harvard Medical School and MassGeneral Hospital for Children. Massachusetts General Hospital. Methodist Hospital. Tufts University School of Medicine. Beth Israel Deaconess Medical Center. Medical University of South

Review of the Pathologic Characteristics in Myhre Syndrome: Gain-of-Function Pathogenic Variants in SMAD4 cause a Multisystem Fibroproliferative Response Read More »

MRI evaluation of right heart functions in children with mild cystic fibrosis

Hafize Otcu Temur, Alpay Alkan, Can Yilmaz Yozgat, Erkan Cakir, Hakan Yazan, Fatma Celik Yabul, Dilek Hacer Cesme, Yilmaz YozgatBezmialem Vakif University. Istanbul Medipol University.Turkey Cardiology in the YoungCardiol Youg 2022; 13: DOI: 10.1017/S1047951122003249 AbstractBackground: This study aimed to assess the ventricular anatomy, function of the right ventricle, and the haemodynamic findings of pulmonary artery in children

MRI evaluation of right heart functions in children with mild cystic fibrosis Read More »

Alveolar dead space fraction is not associated with early RV systolic dysfunction in pediatric ARDS

Daniel Chilcote, Laura Mercer-Rosa, Yan Wang, Steven M. Kawut, Robert A. Berg, Nadir Yehya, Adam S. HimebauchPerelman School of Medicine at the University of Pennsylvania and Children’s Hospital of Philadelphia. United States Pediatric PulmonologyPediatr Pulmonol 2023; 58: 559-565DOI: 10.1002/ppul.26237 AbstractPrimary hypothesis: We hypothesized that higher alveolar dead space fraction (AVDSf) at pediatric acute respiratory distress syndrome (PARDS)

Alveolar dead space fraction is not associated with early RV systolic dysfunction in pediatric ARDS Read More »

Outpatient prescription of pulmonary vasodilator therapy to preterm children with bronchopulmonary dysplasia

Ida Jeremiasen, Karin Tran-Lundmark, Mikaela Dolk, Estelle NaumburgLund University and Skåne University Hospital. Umeå University.Sweden Acta PaediatricaActa Paediatr 2023; 112: 409-416DOI: 10.1111/apa.16615 Abstract Aim: The use of pulmonary vasodilator therapy in children born preterm is largely unknown. Our aim was to map prescription patterns in children with bronchopulmonary dysplasia in Sweden.Methods: This was a descriptive national registry-based study

Outpatient prescription of pulmonary vasodilator therapy to preterm children with bronchopulmonary dysplasia Read More »

Pharmacokinetics of L-Citrulline in Neonates at Risk of Developing Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension

Candice D. Fike, Charul Avachat, Angela K. Birnbaum, Judy L. Aschner, Catherine M. SherwinUniversity of Utah Health. University of Minnesota. Hackensack Meridian School of Medicine. Wright State University Boonshoft School of Medicine and Dayton Children’s Hospital.United States Paediatric DrugsPaediatr Drug 2023; 25: 87-96DOI: 10.1007/s40272-022-00542-x AbstractBackground: Options to treat pulmonary hypertension (PH) in neonates with bronchopulmonary dysplasia (BPD)

Pharmacokinetics of L-Citrulline in Neonates at Risk of Developing Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension Read More »

Scroll to Top